Resistin targets TAZ to promote osteogenic differentiation through PI3K/AKT/mTOR pathway.

Shang J, Yu Z, Xiong C, Zhang J, Gong J, Yu C, Huang Y, Zhou X

DOI: 10.1016/j.isci.2023.107025
Published: 2023 Jul 21
Container: iScience
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.isci.2023.107025,
  title = {Resistin targets TAZ to promote osteogenic differentiation through PI3K/AKT/mTOR pathway.},
  author = {Shang J and Yu Z and Xiong C and Zhang J and Gong J and Yu C and Huang Y and Zhou X},
  year = {2023},
  journal = {iScience},
  doi = {10.1016/j.isci.2023.107025},
  url = {https://doi.org/10.1016/j.isci.2023.107025}
}

RIS

TY  - JOUR
TI  - Resistin targets TAZ to promote osteogenic differentiation through PI3K/AKT/mTOR pathway.
AU  - Shang J
AU  - Yu Z
AU  - Xiong C
AU  - Zhang J
AU  - Gong J
AU  - Yu C
AU  - Huang Y
AU  - Zhou X
PY  - 2023
JO  - iScience
DO  - 10.1016/j.isci.2023.107025
UR  - https://doi.org/10.1016/j.isci.2023.107025
ER  -

APA

J, S., Z, Y., C, X., J, Z., J, G., C, Y., Y, H., & X, Z. (2023). Resistin targets TAZ to promote osteogenic differentiation through PI3K/AKT/mTOR pathway.. iScience. https://doi.org/10.1016/j.isci.2023.107025

Source records

pubmed · retrieved 2026-09-26T15:18:25.230Z